Tumor Ablation Market Global News - Growing Awareness About Ablation Procedures Over Conventional Therapeutic and Surgical Procedures
This report analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the World (RoW).
(EMAILWIRE.COM, March 28, 2019 ) Technological advancements in the field of tumor ablation coupled with increased procedural safety profile, rising market demand of minimal invasive tumor ablation techniques, increasing prevalence of cancer across the globe, as well as growing number of public-private initiatives & funding to support ongoing research activities related to tumor ablation are propelling the growth of the market.
However, factors such as unfavorable regulatory policies and cost containment measures adopted by various governments are restraining the optimal market growth.
This market has evolved significantly in the last two decades. This can primarily be attributed to the emergence of various technologically advanced devices, such as multi-polar and bipolar electrodes, temperature-controlled and fluid-cooled ablation catheters, and imaging and contact force measuring sensors.
Download the PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=142550258
Most of the leading manufacturers and new market entrants are investing heavily in R&D activities to develop novel tumor ablation products and to expand the clinical application profile of their existing tumor ablation products. In line with this strategy, from 2013 to 2016, the global market witnessed several initiatives by key players (Covidien, Plc, Medtronic, Inc., NeuWave Medical, Inc., and SonaCare Medical, LLC, among others) to strengthen their R&D capabilities.
The microwave tumor ablation technology is the fastest-growing ablation technology segment that is currently being used to treat various cancers (such as liver, lung, and kidney).
Growth in the in microwave ablation segment is attributed to increasing private funding for novel product development of microwave ablation, its significant efficiency over other ablation technologies, and growing adoption of the microwave tumor ablation procedure among healthcare professionals to treat various cancers.
Surgical tumor ablation is a minimally invasive surgical procedure in which ablation probes/catheters are used to deliver energy directly to the cancer site for treatment. This does not involve surgical removal of affected tissues or tumors. Surgical ablation is performed on patients ineligible for the surgical removal of tumor/cancer tissue.
The stable market growth witnessed by the surgical tumor ablation segment is mainly due to the large number of minimally invasive surgical procedures performed in mature markets (such as the U.S., the U.K., Italy, Germany, and Japan) to treat various cancers, growing market awareness about the benefits of surgical ablation in emerging markets (coupled with rapid modernization of regional healthcare infrastructure), and large proportion of cancer patients ineligible for surgical cancer treatment (paired with growing patient base for key cancers such as liver, kidney, lung, and prostate).
Get the Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=142550258
As of 2015, Angiodynamics, Inc. (U.S.), Boston Scientific Corporation (U.S.), Galil Medical, Inc. (U.S.), EDAP TMS S.A. (France), Healthtronics, Inc. (U.S.), Medtronic, Plc (U.S.), Mermaid Medical, Inc. (Denmark), Mesonix, Inc. (U.S.), Neuwave Medical, Inc. (U.S.), and Sonacare Medical, LLC (U.S.) are key players operating in the global tumor ablation market.
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
Media Contact
- Mr. Shelly Singh
- raviraj.tak@marketsandmarkets.com